FBRX_OUT_1 [2025-03-20 15:05:52 -0400] 1977 Bytes | 586 tokens | Cum: 586 tkns (7.32% of 8k)
==========================================================================

Booyah, my friends! It's already 03:05:50 PM on Thursday March 20, 2025 ET (UTC-0400), and I've got my eyes locked on Forte Biosciences (FBRX), pushing up to 8.48 from 7.02. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

Here's the first list of news for Forte Biosciences:

C1 - Feb-03-25 09:00AM - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
C2 - Nov-25-24 09:00AM - Forte Biosciences to Host RandD Day December 3, 2024
C3 - Nov-25-24 09:00AM 09:00AM - Forte Biosciences to Host R&D Day December 3, 2024
C4 - Nov-20-24 09:00AM - Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
C5 - Nov-14-24 04:01PM - Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
C6 - Aug-26-24 11:51AM - Upcoming Stock Splits This Week (August 26 to August 30) Stay Invested
C7 - Aug-14-24 09:54PM - FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024
C8 - Aug-14-24 09:54PM 04:01PM - Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Forte Biosciences (FBRX)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

FBRX_OUT_3 [2025-03-20 15:05:58 -0400] 552 Bytes | 149 tokens | Cum: 737 tkns (9.21% of 8k)
==========================================================================

Showing C4 (chunk 1 of 1): C4:
**Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications**
Date: Nov-20-24 09:00AM
Source: (Business Wire)
URL: https://www.businesswire.com/news/home/20241120549128/en/

Error fetching article: 403 Client Error: Forbidden for url: https://www.businesswire.com/news/home/20241120549128/en/

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_5 [2025-03-20 15:05:59 -0400] 674 Bytes | 194 tokens | Cum: 1023 tkns (12.79% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-02-28T21:25:23Z - Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update...
A2 - 2025-02-20T07:51:59Z - Forte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX)...
A3 - 2025-02-19T11:03:21Z - One Forte Biosciences Insider Raised Stake By 273% In Previous Year...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

FBRX_OUT_7 [2025-03-20 15:06:01 -0400] 1038 Bytes | 304 tokens | Cum: 1329 tkns (16.61% of 8k)
==========================================================================

Showing A1 (chunk 1 of 5): A1:
**Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update**Date: 2025-02-28Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/forte-biosciences-inc-nasdaqfbrx-short-interest-update-2025-02-27/Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 28,300 shares, a decrease of 79.0% from the January 31st total of 134,600 shares. Based on an average daily trading volume, of 546,400 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.6% of the shares of the stock are sold short.

Forte Biosciences Trading Down 0.2 %

Shares of FBRX stock traded down $0.02 during trading hours on Thursday, hitting $9.30. 24,145 shares of the company were exchanged, co

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_9 [2025-03-20 15:06:02 -0400] 788 Bytes | 264 tokens | Cum: 1595 tkns (19.94% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-03-25T16:00:10Z - What Makes Forte Biosciences (FBRX) a New Buy Stock
B2 - 2023-12-13T13:29:24Z - Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying
B3 - 2023-12-11T13:34:01Z - RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
B4 - 2023-11-24T11:38:00Z - Insiders Buying Vintage Wine Estates And 3 Other Stocks Under $1
B5 - 2023-04-06T19:53:22Z - Penny Stocks To Buy Now? 4 To Watch In April
B6 - 2022-07-13T08:59:07Z - Boeing, PriceSmart And 80 Biggest Movers From Yesterday

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

FBRX_OUT_11 [2025-03-20 15:06:05 -0400] 486 Bytes | 143 tokens | Cum: 1740 tkns (21.75% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**What Makes Forte Biosciences (FBRX) a New Buy Stock**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2245625/what-makes-forte-biosciences-fbrx-a-new-buy-stockForte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_13 [2025-03-20 15:06:07 -0400] 1088 Bytes | 313 tokens | Cum: 2097 tkns (26.21% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S3 - 2024-11-20 8-K Item1.01. Entry into a Material Definitive Agrmt.

Securities Purchase Agrmt

On November 19, 2024, Forte Biosciences, Inc. (the Company) entered into a Securities Purchase Agrmt (the Purchase Agrmt) for a private placement (the Private Placement) with certain q...

S4 - 2024-11-20 8-K Item1.01. Entry into a Material Definitive Agrmt.

Securities Purchase Agrmt

On November 19, 2024, Forte Biosciences, Inc. (the Company) entered into a Securities Purchase Agrmt (the Purchase Agrmt) for a private placement (the Private Placement) with certain q...

S5 - 2024-11-14 10-Q PART I F INANCIAL INFO

Item 1: Fin Stmnts

FORTE BIOSCIENCES, INC.

COND CONS BA LANCE SHEETS

(in thousands, except share and par value data)

September 30, 2024

December 31, 2023

(unaudited)

Assets

Curr assets:

Cash and cash equ...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

FBRX_OUT_15 [2025-03-20 15:06:09 -0400] 1038 Bytes | 243 tokens | Cum: 2342 tkns (29.28% of 8k)
==========================================================================

Showing S3 (chunk 1 of 6): S3:
Item1.01. Entry into a Material Definitive Agreement.

Securities Purchase Agreement

On November 19, 2024, Forte Biosciences, Inc. (the Company) entered into a Securities Purchase Agreement (the Purchase Agreement) for a private placement (the Private Placement) with certain qualified institutional buyers, institutional accredited investors and certain executive officers and senior management (each, a Purchaser and collectively, the Purchasers). Pursuant to the Purchase Agreement, the Company agreed to sell to the Purchasers (i) 4,931,389 shares of the Companys common stock, par value $0.001 per share (the Shares), at a purchase price of $5.552 per Share, representing the average of the Nasdaq Official Closing Price of the Companys Common Stock (as reflected on Nasdaq.com) for the five trading days immediately preceding the signing of the Purchase Agreement, and (ii) pre-funded wa

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_17 [2025-03-20 15:06:10 -0400] 1038 Bytes | 241 tokens | Cum: 2585 tkns (32.31% of 8k)
==========================================================================

Showing S3 (chunk 2 of 6): rrants (the Pre-Funded Warrants) to purchase 4,615,555 shares of Common Stock (the Warrant Shares and together with the Shares and the Pre-Funded Warrants, the Securities), at a purchase price of $5.551 per Pre-Funded Warrant, provided that each Purchaser may elect to change its allocation of Shares and Pre-Funded Warrants prior to closing. The Pre-Funded Warrants will have an exercise price of $0.001 per share of Common Stock, be immediately exercisable and remain exercisable until exercised in full. The holders of Pre-Funded Warrants may not exercise a Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or such lower percentage as determined by each Purchaser. The holders of Pre-Funded Warrants may increase or decrease such percentages

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_19 [2025-03-20 15:06:24 -0400] 4735 Bytes | 1378 tokens | Cum: 3965 tkns (49.56% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| Volume: 27,732 | SMA50: -32.24% | Market Cap: 50.35M | Option/Short: No / Yes | Sales past 5Y: 0.00% | Sales Surprise: - |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| Avg Volume: 38.81K | SMA200: -32.42% | Shs Outstand: 6.39M | Short Float: 0.24% | Employees: 9 | EPS Surprise: 28.32% |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| Rel Volume: 0.86 | Perf Week: 31.25% | Shs Float: 5.17M | Short Ratio: 0.32 | Debt/Eq: 0.00 | P/E: - |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| RSI (14): 45.61 | Perf Month: -21.33% | Inst Own: 69.10% | Short Interest: 0.01M | Sales Y/Y TTM: - | Earnings: Nov 14 AMC |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| ATR (14): 1.08 | Perf Quarter: -58.47% | Insider Own: 19.14% | Beta: 2.57 | ROE: -137.40% | |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| SMA20: 6.31% | Index: - | Insider Trans: 1.87% | Sales Q/Q: - | ROI: -365.10% | |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Inside Trans: Forte Biosciences, Inc. (FBRX) by Wagner Paul A. (SEE REMARKS) on 2025-01-01
- Common Stock: 1250 shares at $0 (D)
- Common Stock: 164 shares at $22.71 (D)
- Restricted Stock Units: 1250 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Riley Antony A (CHIEF FINANCIAL OFFICER) on 2025-01-01
- Common Stock: 375 shares at $0 (D)
- Common Stock: 154 shares at $22.71 (D)
- Restricted Stock Units: 375 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: Forte Biosciences, Inc. Common Stock
Market Cap: N/A
Shares Outstanding: N/A
Sector: PHARMACEUTICAL PREPARATIONS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 1124000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -34195000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 8.4
Average Volume: 25119.91
30-Day High: 11.23
30-Day Low: 5.5

[Detailed Financials: Q3 2024]
- Total Assets: $17,946,000.0
- Total Liabilities: $8,580,000.0
- Total Equity: $9,366,000.0
- Current Assets: $17,668,000.0
- Current Liabilities: $8,580,000.0

[Income Statement: Q3 2024]
- Revenue: $0
- Net Income: $-8,392,000.0
- Operating Income: $-8,629,000.0
- Earnings Per Share (EPS): -4.54

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-8,135,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $26,078,000.0
- Total Liabilities: $-16,961,000.0
- Total Equity: $16,961,000.0
- Current Assets: $25,711,000.0
- Current Liabilities: $9,117,000.0

[Income Statement: Q2 2024]
- Revenue: $0
- Net Income: $-12,511,000.0
- Operating Income: $-12,818,000.0
- Earnings Per Share (EPS): -0.27

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-5,946,000.0
==== END OF FINANCIAL REPORT ====

Now we've reached the end of the analysis.
You are now requested to make a summary analysis.
Please don't explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.
Please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

FBRX_OUT_21 [2025-03-20 15:06:26 -0400] 561 Bytes | 131 tokens | Cum: 4411 tkns (55.14% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings & insider data
-> X3 <- Broader sector & market news
-> X4 <- General market sentiment & AI confidence levels
-> X5 <- AI's past analysis on similar companies
-> X6 <- More financial metrics
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

FBRX_IN_23 [2025-03-20 15:06:27 -0400] 126 Bytes | 29 tokens | Cum: 4447 tkns (55.59% of 8k)
==========================================================================

====================================
[2025-03-20 12:06:27] # Analysis Completed
Elapsed Time: 37.00 seconds